Skip to content

Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

Texting in Community Health Center Dental Clinics to Reduce HIV Risk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06088277
Enrollment
266
Registered
2023-10-18
Start date
2024-08-16
Completion date
2027-04-14
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Dental patients, Community Health Center Dental Clinics, Text messaging, HIV negative, HIV testing

Brief summary

This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.

Interventions

BEHAVIORALTM HIV

Participants will receive 5 intervention text messages (TM) about HIV risk and testing per week for the first 3 months and 3 messages per week for the last 3 months of the intervention.

BEHAVIORALTM HL

Participants will receive 5 intervention text messages (TM) about promoting healthy living (HL) per week for the first 3 months and 3 messages per week for the last 3 months of the intervention.

Sponsors

Boston University
Lead SponsorOTHER
National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Give informed consent and document consent via a signed and dated informed consent form in REDCap * Willing to comply with all study procedures and be available for the duration of the study * Be able to read either in English or Spanish * Be a dental clinic patient of record at one of our participating community health centers * Has at least one risk factor for HIV defined as self-report of at least one of the following: Men who have sex with men; multiple sex partners, or intravenous drug use

Exclusion criteria

* Self-report of having HIV infection * Participating in another HIV study or another text message study * A woman who reports having sex exclusively with women * Does not have a mobile phone or other device which can receive text messages from Agile Health * Does not have unlimited texting on their mobile plan * Has not used any type of text messaging at least once in the past month * Single item literacy screening score of 2 or below.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants that obtain HIV testing12 monthsThe total number of participants that obtain HIV testing will be assessed from answers to a question in a study questionnaire.

Secondary

MeasureTime frameDescription
Intravenous Drug Use (IDU)3 months, 6 months, 12 monthsAmong participants reporting IDU, percentage of participants who report using clean needles since the start of the intervention
Self-efficacy score6 months, 12 monthsThis outcome will be assessed using a one-item measure with a 5-point Likert scale where: 1 = "Not at all", 2 = "Somewhat", 3 = "Undecided", 4 = "Not really", and 5 = "Very much". HIgher scores are more favorable.
Motivation to perform behaviours that reduce HIV risk3 months, 6 months, 12 monthsThis outcome will be assessed using a one-item measure with a 5-point Likert scale where: 1 = "Not at all", 2 = "Somewhat", 3 = "Undecided", 4 = "Not really", and 5 = "Very much". HIgher scores are more favorable.
Outcome expectations regarding behaviors to reduce HIV risk.3 months, 6 months, 12 monthsThis outcome will be assessed using a one-item measure with a 5-point Likert scale where: 1 = "Not at all", 2 = "Somewhat", 3 = "Undecided", 4 = "Not really", and 5 = "Very much". HIgher scores are more favorable.
PrEp Uptake3 months, 6 months, 12 monthsPercentage of participants who started PrEP since the last assessment
Condom use3 months, 6 months, 12 monthsPercentage of participants who used condoms consistently within the last month or at their last sexual encounter since the start of the intervention.
Adherence to pre-exposure prophylaxis (PrEP)baseline, 3 months, 6 months, 12 monthsParticipants will be asked to complete a study questionnaire where they will be asked if they adhered to PrEP.

Countries

United States

Contacts

CONTACTMichelle Henshaw, DDS, MPH
mhenshaw@bu.edu:617-358-6111
CONTACTGabriel Federo Hungria, MD, MSCR
gfedero@bu.edu617-358-6490
PRINCIPAL_INVESTIGATORMichelle Henshaw, DDS, MPH

Boston University Goldman School of Dental Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026